Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer
NCT05965102
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG:
Tirelizumab；Chemotherapy monotherapy
Sponsor
Second Affiliated Hospital of Guangzhou Medical University